Skip to main content
Equibles
VRDN $23.06 +4.44%
VRDN logo

VRDN · Viridian Therapeutics, Inc.\DE

Track VRDN — free

Use VRDN with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about VRDN

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$23.06 +0.98 (+4.44%)
Market Cap
$2.50B
Shares
113.29M
All earnings calls

Earnings call · FY2026 Q1

Viridian Therapeutics, Inc.DE Q1 FY2026 Earnings Call

Viridian Therapeutics, Inc.DE Q1 FY2026 Earnings Call

Concluded May 5, 2026
May 5, 2026 0 turns
Period
FY2026 Q1
Runtime
—
Sources
2 artifacts
8-K 10-Q

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.

Research coverage

2 live sources

Switch sources without leaving this page or losing your listening position.

Revenue $141,000 +95.8% YoY
Net income -$104.90M

Research materials

Open the source you need; every reader stays inside this workspace.

8-K earnings release Filed May 5, 2026 10-Q report Filed May 5, 2026 Company webcastOpen the original investor-relations page

Quarter detail

How the reported period landed and where the business moved.

Revenue · products & services

Collaboration$135,000 +87.5% YoY
License$6,000
Full-screen source Call document

Report a Problem

Category
Description
Email (optional, for follow-up)